The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Next-generation sequencing (NGS) in metastatic colorectal cancer (CRC) patients (pts) in Israel.
Ayala Hubert
No relevant relationships to disclose
Ravit Geva
No relevant relationships to disclose
Amiel Segal
No relevant relationships to disclose
Baruch Brenner
No relevant relationships to disclose
Ronen M. Brenner
No relevant relationships to disclose
Sharon Pelles-Avraham
No relevant relationships to disclose
Alexander Beny
No relevant relationships to disclose
David Sarid
No relevant relationships to disclose
Shoshana P. Keren-Rosenberg
No relevant relationships to disclose
Salomon M. Stemmer
No relevant relationships to disclose
Alberto Gabizon
No relevant relationships to disclose
Ofer Purim
No relevant relationships to disclose
Esther Tahover
No relevant relationships to disclose
Moshe J. Inbar
No relevant relationships to disclose
Ido Wolf
No relevant relationships to disclose
Addie Dvir
Employment or Leadership Position - Teva
Lior Soussan-Gutman
Employment or Leadership Position - Teva
Jeffrey S. Ross
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Phil Stephens
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Vincent A. Miller
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine